Laura A. Singer Amicus Therapeutics

Laura Singer is the Vice President of Global Quality at Amicus Therapeutics headquartered in Cranbury, NJ with responsibility for all aspects of clinical development and commercial Quality.  She joined Amicus in 2015 to lead the Quality organization through the design and build of their Quality Systems to support the anticipated launch of their first commercial product.  Laura has worked in the rare disease field for the last seven years and was previously with Shire through the acquisition of NPS Pharmaceuticals.  Laura has been in the Pharmaceutical/Biotechnology industry for 28 years and much of that time she has spent spearheading the development and organizational design of Quality functions and Quality systems to effectively support various business models and programs.  Her expertise and interests includes Quality Systems, organizational design and inspection management.